Current clinical assessments of neurological diseases, such as Parkinson's, are limited to infrequent in-person evaluations, providing only a snapshot of the patient's condition. This leads to challenges in accurately tracking disease progression and adjusting treatments effectively, especially given the symptom fluctuations over short periods. There is a need for a continuous, objective, and accessible assessment method leveraging mobile technology to enhance disease management and early detection.
A mid-sized healthcare organization or research institution seeking innovative tools for monitoring neurological disease progression and early detection through patient-centered mobile solutions.
The deployment of the mobile monitoring app is expected to enable objective, continuous assessment of neurological symptoms, leading to more accurate tracking of disease progression and earlier detection. This can reduce the frequency of in-clinic visits, improve treatment personalization, and ultimately enhance patient outcomes. Quantitatively, it aims to provide objective assessments that are less reliant on subjective observations, resulting in improved diagnosis accuracy and treatment adjustments.